Safety and efficacy of autoantigen‐specific therapy with 2 doses of alum‐formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
Helena Elding Larsson; Markus Lundgren; Berglind Jonsdottir; David Cuthbertson; Jeffrey Krischer
Author Information: Department of Clinical Sciences/CRC, Skåne University Hospital
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.